ATE452185T1 - Dimethylarginin-dimethylaminohydrolasen - Google Patents
Dimethylarginin-dimethylaminohydrolasenInfo
- Publication number
- ATE452185T1 ATE452185T1 AT00901731T AT00901731T ATE452185T1 AT E452185 T1 ATE452185 T1 AT E452185T1 AT 00901731 T AT00901731 T AT 00901731T AT 00901731 T AT00901731 T AT 00901731T AT E452185 T1 ATE452185 T1 AT E452185T1
- Authority
- AT
- Austria
- Prior art keywords
- dimethylarginine
- dimethylaminohydrolases
- ddahs
- activators
- genes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9901705.5A GB9901705D0 (en) | 1999-01-26 | 1999-01-26 | Screen method |
| GBGB9913066.8A GB9913066D0 (en) | 1999-06-04 | 1999-06-04 | Screen method |
| PCT/GB2000/000226 WO2000044888A2 (en) | 1999-01-26 | 2000-01-26 | Dimethylarginine dimethylaminohydrolases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE452185T1 true ATE452185T1 (de) | 2010-01-15 |
Family
ID=26315038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00901731T ATE452185T1 (de) | 1999-01-26 | 2000-01-26 | Dimethylarginin-dimethylaminohydrolasen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050153315A1 (de) |
| EP (1) | EP1144605B1 (de) |
| JP (1) | JP2002535001A (de) |
| AT (1) | ATE452185T1 (de) |
| AU (1) | AU2303800A (de) |
| DE (1) | DE60043533D1 (de) |
| ES (1) | ES2336416T3 (de) |
| WO (1) | WO2000044888A2 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0020449D0 (en) * | 2000-08-18 | 2000-10-11 | Univ London | Crystal structure |
| US7381701B2 (en) | 2001-02-15 | 2008-06-03 | The Borad Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| US9096663B2 (en) | 2001-02-15 | 2015-08-04 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
| US7556810B2 (en) | 2005-07-19 | 2009-07-07 | The Board Of Trustees Of The University Of Ilinois | Compositions and methods to control angiogenesis with cupredoxins |
| US20040214264A1 (en) * | 2002-04-19 | 2004-10-28 | Veli-Pekka Valkonen | Nucleic acid molecule encoding a variant DDAH 1 protein and uses thereof |
| GB0211295D0 (en) * | 2002-05-16 | 2002-06-26 | Univ London | Treatment of pain |
| GB0211297D0 (en) * | 2002-05-16 | 2002-06-26 | Univ London | Pain treatment |
| CN1656123A (zh) * | 2002-05-31 | 2005-08-17 | 尤尼特尔药品公司 | 用于评估心血管疾病危险性的蛋白和方法 |
| US9434770B2 (en) | 2004-10-07 | 2016-09-06 | Tapas K Das Gupta | Modified cupredoxin derived peptides |
| US10675326B2 (en) | 2004-10-07 | 2020-06-09 | The Board Of Trustees Of The University Of Illinois | Compositions comprising cupredoxins for treating cancer |
| UA97466C2 (ru) | 2004-10-07 | 2012-02-27 | Ананда Чакрабарти | Транспортирующие соединения - производные купредоксина и способы их применения |
| US8232244B2 (en) | 2007-02-08 | 2012-07-31 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to prevent cancer with cupredoxins |
| US9968685B2 (en) | 2004-10-07 | 2018-05-15 | Brad N. Taylor | Methods to treat cancer with cupredoxins |
| US9598470B2 (en) | 2004-10-07 | 2017-03-21 | Craig W. Beattie | Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways |
| EP1904642A4 (de) | 2005-07-19 | 2008-11-26 | Univ Illinois | Transportmittel zur überquerung der blut-hirn-schranke und zum eindringen in gehirnkrebszellen sowie verwendungsverfahren dafür |
| SG174136A1 (en) * | 2009-02-20 | 2011-10-28 | Cdg Therapeutics Inc | Compositions and methods to prevent and/or treat cancer with pa -card |
| US8486179B2 (en) * | 2009-10-29 | 2013-07-16 | Georgia Tech Research Corporation | Method for producing carbon molecular sieve membranes in controlled atmospheres |
| US20120315281A1 (en) * | 2011-05-13 | 2012-12-13 | The Penn State Research Foundation | Treatment of renal injury |
| WO2019028040A1 (en) * | 2017-07-31 | 2019-02-07 | Vasculonics Llc | MODIFIED DDAH POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCEMENT FRAGMENT WITH ENHANCED PHARMACOLOGY AND USES THEREOF |
| CA3154382A1 (en) | 2019-09-13 | 2021-03-18 | The Trustees Of Indiana University | Devices and methods for modulating adma in blood |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0965876A (ja) * | 1995-08-31 | 1997-03-11 | Green Cross Corp:The | 動物細胞の振盪培養方法および培養容器 |
| EP0929681B1 (de) * | 1996-08-20 | 2006-09-13 | Novartis AG | Rifamycin biosynthese genkluster |
| US6607879B1 (en) * | 1998-02-09 | 2003-08-19 | Incyte Corporation | Compositions for the detection of blood cell and immunological response gene expression |
| DE19820190A1 (de) * | 1998-04-28 | 1999-11-04 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor |
| JP2003528567A (ja) * | 1998-11-12 | 2003-09-30 | インサイト・ファーマスーティカルズ・インコーポレイテッド | ヒトヒドロラーゼタンパク質 |
-
2000
- 2000-01-26 AT AT00901731T patent/ATE452185T1/de not_active IP Right Cessation
- 2000-01-26 ES ES00901731T patent/ES2336416T3/es not_active Expired - Lifetime
- 2000-01-26 WO PCT/GB2000/000226 patent/WO2000044888A2/en not_active Ceased
- 2000-01-26 DE DE60043533T patent/DE60043533D1/de not_active Expired - Lifetime
- 2000-01-26 JP JP2000596131A patent/JP2002535001A/ja active Pending
- 2000-01-26 EP EP00901731A patent/EP1144605B1/de not_active Expired - Lifetime
- 2000-01-26 AU AU23038/00A patent/AU2303800A/en not_active Abandoned
-
2004
- 2004-10-18 US US10/966,039 patent/US20050153315A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002535001A (ja) | 2002-10-22 |
| EP1144605A2 (de) | 2001-10-17 |
| WO2000044888A2 (en) | 2000-08-03 |
| EP1144605A3 (de) | 2002-03-27 |
| AU2303800A (en) | 2000-08-18 |
| WO2000044888A3 (en) | 2001-12-13 |
| ES2336416T3 (es) | 2010-04-13 |
| US20050153315A1 (en) | 2005-07-14 |
| EP1144605B1 (de) | 2009-12-16 |
| DE60043533D1 (de) | 2010-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60043533D1 (de) | ||
| BR9909248A (pt) | Inibidores de enzima | |
| DE69936720D1 (de) | Menschliche cd45+ und/oder fibroblasten+ mesenchymale stammzellen | |
| NO20052928L (no) | Nye kjemiske forbindelser | |
| NO20051788L (no) | Hydantoinderivater og deres anvendelse som TACE-inhibitorer | |
| NO20050497L (no) | Anvendelse av CETP inhibitorer og eventuelt HMG COA reduserbare inhibitorer og/eller antihypertensiva | |
| NO20035086L (no) | Karboksylsyresubstituerte oxazolderivater for anvendelse som PPAR-alfa og gamma-aktivatorer i behandling av diabetes | |
| NO20033742L (no) | Omega-aminoalkylamider av R-2-arylpropionsyrer som inhibitorer av polymofonukle¶re og mononukle¶re cellers kjemotakse | |
| TR199802441A2 (xx) | Kanda a��r� �rik asit bulunmas�n�n tedavisi ve �nlenmesi i�in y�ntem ve terkip. | |
| DK0755249T3 (da) | Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom | |
| NO20071019L (no) | Quinazolinderivater og deres anvendelse ved behandling av trombocytemi | |
| DE60214542D1 (de) | Verwendung von cox2 inhibitoren zur behandlung von schizophrenia und des ticks | |
| EP1191941A4 (de) | Methode der prophylaxe und/oder behandlung von erkrankungen | |
| MY117526A (en) | N-(3-benzofuranyl)urea-derivatives | |
| HUS1000019I1 (hu) | Karbonsav-tartalmú szerek és növénytermesztésben való alkalmazásuk | |
| DE69931055D1 (de) | Verwendung von cyclooxygenase-2-inhibitoren zur behandlung von entzündungserkrankungen von kopf und nacken | |
| NO971444D0 (no) | Inhibitor av stamcelle-proliferasjon og anvendelser derav | |
| DE50308707D1 (de) | Abbau und modifizierung von silicaten und siliconen durch silicase und verwendung des reversiblen enzyms | |
| ATE446077T1 (de) | Vektoren mit beiden isoformen von beta- hexosaminidase | |
| NO20020130L (no) | Anvendelse av FVIIa eller en vevsfaktorantagonist til regulering av genekspresjon og cellemigrasjon eller kjemotaksis | |
| DE60224004D1 (de) | Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten | |
| EP1572901A4 (de) | Transponierbare elemente in reis und verwendungsverfahren | |
| NO20054670L (no) | Behandling av intestinale tilstander med N-2,3,3-tetrametylbisyklo[2.2.1]-heptan-2-amid | |
| JOP20240149A1 (ar) | مثبطات bcl-2 (الخلية ب لمفومة 2) | |
| SG155901A1 (en) | Enzyme inhibitors and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |